Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™)

NCT05403346 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2022-11-16

No results posted yet for this study

Summary

Prospective study that will evaluate the clinical agreement of the CoviDx™ Self test compared to SARS-CoV-2 RT-PCR.

Conditions

Interventions

DEVICE

CoviDx™ Covid-19 Antigen Self-Test

All patients will self-collect a mid-turbinate nasal swab for CoviDx™ Covid-19 Antigen self-testing

Sponsors & Collaborators

  • Rapid Pathogen Screening

    collaborator INDUSTRY
  • Lumos Diagnostics

    lead INDUSTRY

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-17
Primary Completion
2022-08-01
Completion
2022-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05403346 on ClinicalTrials.gov